BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 25845485)

  • 1. Ethical issues raised by a ban on the sale of electronic nicotine devices.
    Hall W; Gartner C; Forlini C
    Addiction; 2015 Jul; 110(7):1061-7. PubMed ID: 25845485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ethics of Tobacco Harm Reduction: An Analysis of E-Cigarette Availability From the Perspectives of Utilitarianism, Bioethics, and Public Health Ethics.
    Thomas R; Parker LS; Shiffman S
    Nicotine Tob Res; 2021 Jan; 23(1):3-8. PubMed ID: 33002156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobacco taxation and public health: ethical problems, policy responses.
    Wilson N; Thomson G
    Soc Sci Med; 2005 Aug; 61(3):649-59. PubMed ID: 15899323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study.
    Pesola F; Phillips-Waller A; Beard E; Shahab L; Sweanor D; Jarvis M; Hajek P
    Public Health Res (Southampt); 2023 Sep; 11(7):1-39. PubMed ID: 37795840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethics of tobacco harm reduction from a liberal perspective.
    van der Eijk Y
    J Med Ethics; 2016 May; 42(5):273-7. PubMed ID: 26612426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State laws prohibiting sales to minors and indoor use of electronic nicotine delivery systems--United States, November 2014.
    Marynak K; Holmes CB; King BA; Promoff G; Bunnell R; McAfee T;
    MMWR Morb Mortal Wkly Rep; 2014 Dec; 63(49):1145-50. PubMed ID: 25503916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult smokers' receptivity to a television advert for electronic nicotine delivery systems.
    Kim AE; Lee YO; Shafer P; Nonnemaker J; Makarenko O
    Tob Control; 2015 Mar; 24(2):132-5. PubMed ID: 24092599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.
    Brandon TH; Goniewicz ML; Hanna NH; Hatsukami DK; Herbst RS; Hobin JA; Ostroff JS; Shields PG; Toll BA; Tyne CA; Viswanath K; Warren GW
    J Clin Oncol; 2015 Mar; 33(8):952-63. PubMed ID: 25572671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology.
    Brandon TH; Goniewicz ML; Hanna NH; Hatsukami DK; Herbst RS; Hobin JA; Ostroff JS; Shields PG; Toll BA; Tyne CA; Viswanath K; Warren GW
    Clin Cancer Res; 2015 Feb; 21(3):514-25. PubMed ID: 25573384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of key stakeholders and smokers on a very low nicotine content cigarette-only policy: qualitative study.
    Fraser T; Kira A
    N Z Med J; 2017 Jun; 130(1456):36-45. PubMed ID: 28571047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Harm reduction strategy in tobacco control].
    Gorini G
    Epidemiol Prev; 2011; 35(3-4 Suppl 1):19-32. PubMed ID: 21926451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of potential electronic nicotine delivery system regulations on nicotine product selection.
    Pesko MF; Kenkel DS; Wang H; Hughes JM
    Addiction; 2016 Apr; 111(4):734-44. PubMed ID: 26639526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of reducing the nicotine content of cigarettes on cigarette smoking behavior and tobacco smoke toxicant exposure: 2-year follow up.
    Benowitz NL; Nardone N; Dains KM; Hall SM; Stewart S; Dempsey D; Jacob P
    Addiction; 2015 Oct; 110(10):1667-75. PubMed ID: 26198394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key issues surrounding the health impacts of electronic nicotine delivery systems (ENDS) and other sources of nicotine.
    Drope J; Cahn Z; Kennedy R; Liber AC; Stoklosa M; Henson R; Douglas CE; Drope J
    CA Cancer J Clin; 2017 Nov; 67(6):449-471. PubMed ID: 28961314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Support for a tobacco endgame and increased regulation of the tobacco industry among New Zealand smokers: results from a National Survey.
    Edwards R; Wilson N; Peace J; Weerasekera D; Thomson GW; Gifford H
    Tob Control; 2013 May; 22(e1):e86-93. PubMed ID: 22535362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the nicotine content of combusted tobacco products sold in New Zealand.
    Donny EC; Walker N; Hatsukami D; Bullen C
    Tob Control; 2017 Mar; 26(e1):e37-e42. PubMed ID: 27672126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four policies to end the sale of cigarettes and smoking tobacco in New Zealand by 2020.
    Laugesen M; Glover M; Fraser T; McCormick R; Scott J
    N Z Med J; 2010 May; 123(1314):55-67. PubMed ID: 20581913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forensic analysis of online marketing for electronic nicotine delivery systems.
    Cobb NK; Brookover J; Cobb CO
    Tob Control; 2015 Mar; 24(2):128-31. PubMed ID: 24038037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of product definitions in US e-cigarette laws and regulations.
    Lempert LK; Grana R; Glantz SA
    Tob Control; 2016 Apr; 25(e1):e44-51. PubMed ID: 25512432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.